Hungary vs Oman: The number of people with susceptibility test result for rifampicin
Hungary
142
in 2021
Oman
144
in 2021
Hungary rank
103rd
Oman rank
102nd
The number of people with susceptibility test result for rifampicin over time
- Hungary
- Oman
How they compare
Oman currently reports 144 against 142 in Hungary, a difference of 2.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Hungary ahead.
Hungary ranks 103rd and Oman ranks 102nd of 155 countries.
Across the 2 decades both report, Hungary averaged higher in 1 and Oman in 1.
Head to head by decade
| Decade | Hungary | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 277.33 | 220.67 | 56.67 | Hungary |
| 2020s | 149 | 181 | 32 | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Hungary or Oman?
- Oman, at 144 against 142 in Hungary as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Hungary and Oman?
- 2, with Oman ahead.
- How many years of comparable data are there for Hungary and Oman?
- 5 years are reported by both, from 2017 to 2021.
- How do Hungary and Oman rank globally for the number of people with susceptibility test result for rifampicin?
- Hungary ranks 103rd and Oman ranks 102nd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.